Sign in

CIK 0000921114

  • Non-accelerated filer
  • Smaller reporting company

Armata Pharmaceuticals, Inc.

Sign in to watch
Ticker
ARMP
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
Operating
EIN
911549568
Phone
+1 310-665-2928
Business address
5005 MCCONNELL AVE, LOS ANGELES, CA, 90066
Former names
AmpliPhi Biosciences Corp, TARGETED GENETICS CORP /WA/
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 22 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-07-10 Birx Deborah Chief Executive Officer Shares withheld for taxes −14,041 $4.26 $60K 198,417
2026-03-14 Birx Deborah Chief Executive Officer Shares withheld for taxes −4,919 $10.54 $52K 212,458
2026-03-09 Birx Deborah Chief Executive Officer Grant or award · Stock Options (Right to Buy) +421,226 421,226
2025-07-10 Birx Deborah Chief Executive Officer Shares withheld for taxes −13,637 $2.27 $31K 217,377
2025-03-14 Birx Deborah Chief Executive Officer Shares withheld for taxes −6,061 $1.95 $12K 231,014
2025-02-05 Birx Deborah Chief Executive Officer Grant or award · Stock Options (Right to Buy) +240,000 240,000
2024-07-10 Birx Deborah Chief Executive Officer Shares withheld for taxes −22,925 $2.68 $61K 237,075
2024-03-14 Birx Deborah Chief Executive Officer Grant or award +60,000 260,000
2024-03-14 Birx Deborah Chief Executive Officer Grant or award · Stock Options (Right to Buy) +240,000 240,000
2023-12-21 Birx Deborah Chief Executive Officer Grant or award +200,000 200,000
2023-12-21 Birx Deborah Chief Executive Officer Grant or award · Stock Options (Right to Buy) +200,000 200,000

Page 1 of 1 · 11 trades